{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:53:34Z","timestamp":1767848014368,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["105-2320-B-182-010"],"award-info":[{"award-number":["105-2320-B-182-010"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.nano.2017.10.006","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T20:31:01Z","timestamp":1510173061000},"page":"215-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Intravenous anti-MRSA phosphatiosomes mediate enhanced affinity to pulmonary surfactants for effective treatment of infectious pneumonia"],"prefix":"10.1016","volume":"14","author":[{"given":"Ching-Yun","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calvin T.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim A.","family":"Aljuffali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Yin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-You","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2017.10.006_bb0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.01.008","article-title":"Current applications of nanoparticles in infectious diseases","volume":"224","author":"Zazo","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.10.006_bb0010","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1128\/AAC.02388-15","article-title":"Pneumonia caused by methicillin-resistant Staphylococcus aureus: does vancomycin heteroresistance matter?","volume":"60","author":"Claeys","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2017.10.006_bb0015","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jconrel.2015.09.004","article-title":"Bio-inspired materials in drug delivery: exploring the role of pulmonary surfactant in siRNA inhalation therapy","volume":"220","author":"De Backer","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.10.006_bb0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10611860902795407","article-title":"Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation","volume":"17","author":"Zhang","year":"2009","journal-title":"J Drug Target"},{"key":"10.1016\/j.nano.2017.10.006_bb0025","first-page":"1463","article-title":"Reducing infections through nanotechnology and nanoparticles","volume":"6","author":"Taylor","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2017.10.006_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jconrel.2015.06.038","article-title":"Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: an animal study","volume":"213","author":"Fang","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.10.006_bb0035","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1517\/17460441.2013.807246","article-title":"Advances in MRSA drug discovery: where are we and where do we need to be?","volume":"8","author":"Kurosu","year":"2013","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.nano.2017.10.006_bb0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/14756360903373350","article-title":"Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects","volume":"25","author":"Sharma","year":"2010","journal-title":"Enzyme Inhib Med Chem"},{"key":"10.1016\/j.nano.2017.10.006_bb0045","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1021\/acs.jmedchem.5b01912","article-title":"Antibacterial diamines targeting bacterial membranes","volume":"59","author":"Wang","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2017.10.006_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.colsurfb.2015.02.022","article-title":"Cationic liposomes evoke inflammatory responses and neutrophil extracellular traps (NETs) toward human neutrophils","volume":"128","author":"Hwang","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2017.10.006_bb0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2217\/nnm.15.217","article-title":"Antimicrobial activity of topically-applied soyaethyl morpholinium ethosulfate micelles against Staphylococcus species","volume":"11","author":"Yang","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2017.10.006_bb0060","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1166\/jbn.2014.1858","article-title":"Nanostructured lipid carriers containing a high percentage of a Pluronic copolymer increase the biodistribution of novel PDE4 inhibitors for the treatment of traumatic hemorrhage","volume":"10","author":"Hsieh","year":"2014","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.nano.2017.10.006_bb0065","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1055\/s-0031-1296229","article-title":"Preparation of ciprofloxacin-coated zinc oxide nanoparticles and their antibacterial effects against clinical isolates of Staphylococcus aureus and Escherichia coli","volume":"61","author":"Seif","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.nano.2017.10.006_bb0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijpharm.2016.10.025","article-title":"Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: design of experiments approach","volume":"515","author":"G\u00fcnday T\u00fcreli","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2017.10.006_bb0075","first-page":"2120734","article-title":"Ciprofloxacin controlled-solid lipid nanoparticles: characterization, in vitro release, and antibacterial activity assessment","volume":"2017","author":"Shazly","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.nano.2017.10.006_bb0080","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/14756360903373350","article-title":"Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects","volume":"25","author":"Sharma","year":"2010","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.nano.2017.10.006_bb0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1389200216666150812124923","article-title":"Nanomedical strategies for targeting skin microbiomes","volume":"16","author":"Aljuffali","year":"2015","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.nano.2017.10.006_bb0090","doi-asserted-by":"crossref","first-page":"16248","DOI":"10.1021\/jp063826h","article-title":"Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity","volume":"110","author":"Panacek","year":"2006","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.nano.2017.10.006_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.colsurfb.2016.01.020","article-title":"New cationic vesicles prepared with double chain surfactants from arginine: role of the hydrophobic group on the antimicrobial activity and cytotoxicity","volume":"141","author":"Pinazo","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2017.10.006_bb0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/AAC.01617-06","article-title":"Quinolone-mediated bacterial death","volume":"52","author":"Drlica","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2017.10.006_bb0105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2015.04.028","article-title":"Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections","volume":"209","author":"Baelo","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.10.006_bb0110","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1021\/jf3010405","article-title":"Characterization, antibiofilm, and mechanism of action of novel PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol","volume":"60","author":"Sun","year":"2012","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.nano.2017.10.006_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/srep18877","article-title":"Potent antibacterial nanoparticles against biofilm and intracellular bacteria","volume":"6","author":"Mu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2017.10.006_bb0120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2014.03.055","article-title":"Lipid and polymer nanoparticles for drug delivery to bacterial biofilms","volume":"190","author":"Forier","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.10.006_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijid.2016.09.005","article-title":"Bacteria in the respiratory tract-how to treat? Or do not treat?","volume":"51","author":"Prat","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.nano.2017.10.006_bb0130","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1128\/AAC.00306-13","article-title":"Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model","volume":"57","author":"Ong","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2017.10.006_bb0135","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s11095-013-1250-x","article-title":"Pharmacological characterization of 7-(4-(piperazin-1-yl)) ciprofloxacin derivatives: antibacterial activity, cellular accumulation, susceptibility to efflux transporters, and intracellular activity","volume":"31","author":"Marquez","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2017.10.006_bb0140","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.nano.2015.11.002","article-title":"Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells","volume":"12","author":"Fromen","year":"2016","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.nano.2017.10.006_bb0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2014.05.034","article-title":"Biodegradable nanoparticles for intracellular delivery of antimicrobial agents","volume":"187","author":"Xie","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.10.006_bb0150","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1128\/AAC.00713-11","article-title":"PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin","volume":"55","author":"Muppidi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2017.10.006_bb0155","first-page":"448","article-title":"Regulation of lung surfactant phospholipid synthesis and metabolism","volume":"2013","author":"Goss","year":"1831","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nano.2017.10.006_bb0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.colsurfb.2014.04.009","article-title":"Cationic vesicles based on biocompatible diacyl glycerol-arginine surfactants: physicochemical properties, antimicrobial activity, encapsulation efficiency and drug release","volume":"120","author":"Tavano","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2017.10.006_bb0165","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10973-006-8061-9","article-title":"Interactions of cationic surfactants with DPPC","volume":"88","author":"Kozak","year":"2007","journal-title":"J Therm Anal Calorim"},{"key":"10.1016\/j.nano.2017.10.006_bb0170","doi-asserted-by":"crossref","first-page":"10672","DOI":"10.1016\/S0021-9258(17)44509-1","article-title":"Reassembly of lipid-protein complexes of pulmonary surfactant","volume":"258","author":"King","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2017.10.006_bb0175","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.addr.2012.05.013","article-title":"Risks and untoward toxicities of antibody-based immunoconjugates","volume":"64","author":"Litvak-Greenfeld","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2017.10.006_bb0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/toxsci\/kfw037","article-title":"Therapeutic antibody-induced vascular toxicity due to off-target activation of nitric oxide in cynomolgus monkeys","volume":"151","author":"Pai","year":"2016","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.nano.2017.10.006_bb0185","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(12)62197-7","article-title":"Transfusion-related acute lung injury: a clinical review","volume":"382","author":"Vlaar","year":"2013","journal-title":"Lancet"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963417301867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963417301867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T21:01:50Z","timestamp":1659819710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963417301867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1549963417301867"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2017.10.006","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous anti-MRSA phosphatiosomes mediate enhanced affinity to pulmonary surfactants for effective treatment of infectious pneumonia","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2017.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}